Late Breaking Clinical Science Abstracts

14 - INSPIRE: Final Results from a Phase 3, Open-Label, Pivotal Study to Evaluate the Safety and Tolerability of LIQ861 in Pulmonary Arterial Hypertension

Presentation Number
14
Speakers
Session Name
SESSION 05 - ORAL: Pulmonary Hypertension: Where We're Going We Don't Need Roads
Date
Wed, Apr 22, 2020
Time
10:30 AM - 12:15 PM
Authors
Audio Upload